Downregulated miR-495 [Corrected] Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.
about
BMI1: A Biomarker of Hematologic MalignanciesTargeting MicroRNAs in Cancer Gene Therapy.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.MicroRNA-495 regulates starvation-induced autophagy by targeting ATG3.
P2860
Downregulated miR-495 [Corrected] Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@ast
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@en
type
label
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@ast
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@en
prefLabel
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@ast
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@en
P2093
P2860
P1433
P1476
Downregulated miR-495 [Correct ...... geting Bmi-1 in Breast Cancer.
@en
P2093
Fang-Yong Lei
Hong-Mei Wu
Jun-Ling Liu
Xiang-Xia Liu
P2860
P356
10.1097/MD.0000000000000718
P407
P577
2015-05-01T00:00:00Z